A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

October 4, 2017

Primary Completion Date

July 1, 2024

Study Completion Date

November 7, 2024

Conditions
Multiple Myeloma
Interventions
DRUG

Modakafusp alfa

Modakafusp alfa intravenous infusion.

DRUG

Dexamethasone

Dexamethasone.

Trial Locations (94)

100

National Taiwan University Hospital, Taipei

10467

Montefiore Medical Center, The Bronx

10676

Evaggelismos General Hospital, Athens

11490

Tri-Service General Hospital, Taipei

11528

Alexandra General Hospital of Athens, Athens

14627

University of Rochester, Rochester

15121

AON SS Antonio e Biagio e Cesare Arrigo, Alessandria

19104

University of Pennsylvania, Philadelphia

21287

Johns Hopkins Hospital, Baltimore

26504

University Regional General Hospital of Patras, Patra

27100

Fondazione IRCCS Policlinico San Matteo, Pavia

27710

Duke University Medical Center, Durham

28041

Hospital Universitario 12 de Octubre, Madrid

28205

Levine Cancer Institute - Concord, Concord

28402

Levine Cancer Center, Charlotte

30120

Hospital Universitario Virgen de la Arrixaca, Murcia

30322

Winship Cancer Institute of Emory University, Atlanta

31059

Centre Hospitalier Universitaire de Toulouse Hopital Purpan, Toulouse

37007

Hospital Universitario de Salamanca, Salamanca

38120

Baptist Cancer Center - Memphis - Walnut Grove, Memphis

39008

Hospital Universitario Marques de Valdecilla, Santander

40138

Azienda Ospedaliero-Universitaria di Bologna - Policlinico Sant'Orsola-Malpighi, Bologna

43210

The Ohio State University, Columbus

44093

Centre Hospitalier Universitaire Nantes - Hotel Dieu, Nantes

46062

Investigative Clinical Research of Indiana, LLC, Noblesville

51101

June E. Nylen Cancer Center, Sioux City

52621

The Chaim Sheba Medical Center, Ramat Gan

55139

Ondokuz Mayis Universitesi Tp Fakultesi, Samsun

58128

Chonnam National University Hwasun Hospital, Hwasun

59020

Hopital Saint-Vincent de Paul - Lille, Lille

59037

Centre Hospitalier Regional Universitaire de Lille, Lille

60126

Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona

60153

Loyola University Medical Center, Maywood

60611

Northwestern Medicine - Northwestern Medical Group, Chicago

67200

Institut de cancerologie Strasbourg Europe, Strasbourg

68198

Univeristy of Nebraska Medical Center, Omaha

72076

Universitatsklinik Tubingen, Tübingen

72762

Highlands Oncology Group, Springdale

75012

Hopital Saint-Antoine, Paris

75015

Hopital Necker-Enfants Malades, Paris

77002

Lumi Research, Houston

86000

Centre Hospitalier Universitaire de Poitiers, Poitiers

89119

USOR - Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas

90069

Office of James R. Berenson MD, West Hollywood

91010

Centre Hospitalier Universitaire Henri Mondor, Créteil

91204

Los Angeles Cancer Network - Glendale Adventist Medical Center, Glendale

92868

University of California Irvine, Orange

95107

Centre Hospitalier d'Argenteuil - Centre Hospitalier Victor Dupouy, Argenteuil

95125

Azienda Ospedaliero - Universitaria Policlinico - Vittorio Emanuele, Catania

97239

Oregon Health and Science University, Portland

100044

Peking University People's Hospital, Beijing

100089

Peking University Third Hospital, Beijing

200003

Shanghai Fourth People's Hospital, Shanghai

210008

Nanjing Drum Tower Hospital, Nanjing

215006

The First Affiliated Hospital of Soochow University - Suzhou First People's Hospital, Suzhou

300060

Tianjin Medical University Cancer Institute & Hospital, Tianjin

310003

The First Affiliated Hospital, Zhejiang University, Hangzhou

430023

Wuhan Union Hospital, Wuhan

430071

Zhongnan Hospital of Wuhan University, Wuhan

450003

Henan Cancer Hospital, Zhengzhou

510060

Sun Yat-Sen University Cancer Center, Guangzhou

6423906

Tel Aviv Sourasky Medical Center, Tel Aviv

9112001

Hadassah Medical Center, Jerusalem

06520

Smilow Cancer Hospital at Yale New Haven, New Haven

02118

Boston Medical Center, Boston

02215

Dana Farber Cancer Institute, Boston

07601

John Theurer Cancer Center, Hackensack

44718-2566

Gabrail Cancer Center, Canton

V5Z 4E6

British Columbia Cancer Agency Vancouver Centre, Vancouver

L8V 5C2

Juravinski Cancer Centre, Hamilton

H2X 0C1

Centre de Recherche du CHUM, Montreal

H3T 1E2

Sir Mortimer B. Davis Jewish General Hospital, Montreal

04103

Universitatsklinikum Leipzig, Leipzig

467-8601

Nagoya City University Hospital, Nagoya

503-8502

Ogaki Municipal Hospital, Gifu

602-855

University Hospital Kyoto Prefectural University of Medicine, Kyoto

701-1192

National Hospital Organization Okayama Medical Center, Okayama

150-8935

Japanese Red Cross Medical Center, Tokyo

0450

Oslo Universitetssykehus-Ulleval Hospital, Oslo

00730

Ad-Vance Medical Research, Ponce

00919

Hospital Espanol Auxilio Mutuo, San Juan

03080

Seoul National University Hospital, Seoul

06591

The Catholic University of Korea - Seoul St. Mary's Hospital, Seoul

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08035

Hospital Universitari Vall d'Hebron, Barcelona

08036

Hospital Clinic de Barcelona, Barcelona

06560

Ankara Universitesi, Yenimahalle

B9 5SS

University Hospitals Birmingham NHS Foundation Trust, Birmingham

TR1 3LI

Royal Cornwall Hospital NHS Trust, Cornwell

NW1 2BU

University College London Hospitals NHS Foundation Trust, London

MK14 6LS

Genesis Care - Milton Keynes, Milton Keynes

OX3 7LE

Oxford University Hospitals NHS Foundation Trust, Oxford

SM2 5PT

The Royal Marsden NHS Foundation Trust, Sutton

SL43HD

Genesis Care Windsor - Genesis Care UK Ltd., Windsor

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03215030 - A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma | Biotech Hunter | Biotech Hunter